Search results: Sage Journals

Restricted accessResearch articleFirst published June, 2020

The impact of corticosteroid use during anti-PD1 treatment

Eva Y Pan, Man Yee Merl, Katherine Lin

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published July, 2020

Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Yulin Wan, Shanshan An, Yanchao Zhou [...]

Cancer Control

Restricted accessCase reportFirst published June, 2021

Accelerated cellular rejection with prominent interstitial hemorrhage following cemiplimab treatment: How can we approach a renal transplant recipient under anti-PD1 therapy?

Evelyn Hermida-Lama, Diana Rodriguez, Elena Cuadrado [...]

Journal of Onco-Nephrology

Open accessResearch articleFirst published 2022

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy

Emma Bigelow, Suchi Saria, Brian Piening [...]

Cancer Informatics

Open accessReview articleFirst published 2023

What is the optimal duration,dose and frequency for anti-PD1 therapy of non-small cell lung cancer?

Chii Yang Kuah, Robert Monfries, Matteo Quartagno [...]

Therapeutic Advances in Medical Oncology

Restricted accessCase reportFirst published March, 2020

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient

Saadettin Kilickap, Deniz C Guven, Oktay H Aktepe [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2021

Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER–Medicare database

Abdulaali R. Almutairi, Marion Slack, Brian L. Erstad [...]

Therapeutic Advances in Drug Safety

Open accessCase reportFirst published 2021

Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab

Candice Hober, Philippe Jamme, Eve Desmedt [...]

Therapeutic Advances in Medical Oncology

Open accessReview articleFirst published 2025

The Role of Immunotherapy in Salivary Gland Cancer: A Systematic Review

Sul Gi Kim, Jason Tasoulas, Siddharth Sheth [...]

Ear,Nose & Throat Journal

Open accessLetterFirst published 2019

A Machine Learning Algorithm for Predicting Therapeutic Response to Anti-PD1

Yuanliang Yan, Shuangshuang Zeng, Xiang Wang [...]

Technology in Cancer Research & Treatment

Restricted accessResearch articleFirst published June, 2020

The impact of corticosteroid use during anti-PD1 treatment

Eva Y Pan, Man Yee Merl, Katherine Lin

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published July, 2020

Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Yulin Wan, Shanshan An, Yanchao Zhou [...]

Cancer Control

Restricted accessCase reportFirst published June, 2021

Accelerated cellular rejection with prominent interstitial hemorrhage following cemiplimab treatment: How can we approach a renal transplant recipient under anti-PD1 therapy?

Evelyn Hermida-Lama, Diana Rodriguez, Elena Cuadrado [...]

Journal of Onco-Nephrology

Open accessResearch articleFirst published 2022

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy

Emma Bigelow, Suchi Saria, Brian Piening [...]

Cancer Informatics

Open accessReview articleFirst published 2023

What is the optimal duration,dose and frequency for anti-PD1 therapy of non-small cell lung cancer?

Chii Yang Kuah, Robert Monfries, Matteo Quartagno [...]

Therapeutic Advances in Medical Oncology

Restricted accessCase reportFirst published March, 2020

Complete responses to two different anti-PD1 agents in a metastatic melanoma patient

Saadettin Kilickap, Deniz C Guven, Oktay H Aktepe [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2021

Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER–Medicare database

Abdulaali R. Almutairi, Marion Slack, Brian L. Erstad [...]

Therapeutic Advances in Drug Safety

Open accessCase reportFirst published 2021

Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab

Candice Hober, Philippe Jamme, Eve Desmedt [...]

Therapeutic Advances in Medical Oncology

Open accessReview articleFirst published 2025

The Role of Immunotherapy in Salivary Gland Cancer: A Systematic Review

Sul Gi Kim, Jason Tasoulas, Siddharth Sheth [...]

Ear,Nose & Throat Journal

Open accessLetterFirst published 2019

A Machine Learning Algorithm for Predicting Therapeutic Response to Anti-PD1

Yuanliang Yan, Shuangshuang Zeng, Xiang Wang [...]

Technology in Cancer Research & Treatment